Clinical Trial Update: Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the combination of cryosurgery and NK cell immunotherapy for metastatic non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cryosurgery
• NK cell immunotherapy

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Non-small Cell Lung Cancer Metastatic | Phase 1, Phase 2 | Status: COMPLETED